Propionaldehyde

Propionaldehyde

SCHEMBL27860273

CCC=O.Fc1cccc(Cl)c1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ GRIN2B Q13224 1/20 0.40
▸ CHRM2 P08172 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ THRB P10828 2/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ PPARG P37231 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ OPRM1 P35372 2/20 0.36
▸ OPRL1 P41146 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaldehyde SCHEMBL27920822 0.86 MEN1 (0.49) MEN1KMT2ARAB9AGRIN2BCHRM2
Propionaldehyde SCHEMBL27792856 0.86 CHRM2 (0.44) KMT2ACHRM2CHRM1CHRM3POLB
SCHEMBL27278405 0.84 MEN1 (0.50) MEN1KMT2ARAB9AGRIN2BACHE
SCHEMBL27690846 0.84 MEN1 (0.50) MEN1KMT2ARAB9AGRIN2BACHE
Alcohol SCHEMBL28020926 0.82 MEN1 (0.49) MEN1KMT2ARAB9AGRIN2BACHE
Chloromethane SCHEMBL27654417 0.81 MEN1 (0.50) MEN1KMT2ARAB9AGRIN2BACHE
Ethane SCHEMBL27840710 0.81 MEN1 (0.50) MEN1KMT2ARAB9AGRIN2BACHE
SCHEMBL29635658 0.81 — —
SCHEMBL165706 0.81 — —
SCHEMBL6201152 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102532106-A Synthesis method of crizotinib serving as antitumor molecular targeting medicament JINAN NIUHUA MEDICAL TECHNOLOGY CO LTD 2012-07-04 — — CN claimed
CN-102532106-A Synthesis method of crizotinib serving as antitumor molecular targeting medicament JINAN NIUHUA MEDICAL TECHNOLOGY CO LTD 2012-07-04 — — CN disclosed
Send feedback